HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
1- methyl- 3- propyl- 7- N,N- dimethylpropylamide- xanthine
structure in first source
Also Known As:
MPDAX cpd
Networked:
1
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Alkaloids: 5398
Xanthines: 123
1-methyl-3-propyl-7-N,N-dimethylpropylamide-xanthine: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
Purinones: 2
Xanthines: 123
1-methyl-3-propyl-7-N,N-dimethylpropylamide-xanthine: 1
Experts
1.
Miyamoto, Ken-Ichi
: 1 article (05/2004)
2.
Sadzuka, Yasuyuki
: 1 article (05/2004)
3.
Sawanishi, Hiroyuki
: 1 article (05/2004)
4.
Sugiyama, Tomomi
: 1 article (05/2004)
5.
Suzuki, Hirokazu
: 1 article (05/2004)
Related Diseases
1.
Neoplasms (Cancer)
05/02/2004 - "
To clarify the effect of 1-methyl-3-propyl-7-N,N-dimethylpropylamide-xanthine (MPDAX) on doxorubicin (DOX) transport, we examined the efficacy of MPDAX as an amplifier of the antitumor activity of DOX in mice bearing tumors with different properties as to DOX transport across cell membranes.
"
Related Drugs and Biologics
1.
Doxorubicin (Adriamycin)